DNAtriX Lands $1,543,905 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4bedbaaf-6bcc-4b23-800d-b2b6945909f7 - Date
11/8/2013 - Company Name
DNAtriX - Mailing Address
One Greenway Plaza Houston, TX 77046 - Company Description
DNAtriX, Inc. is a Texas-based biotechnology company focused on the development of an oncoloytic virus platform initially for the treatment of malignant glioma. DNAtriX’s lead product, delta24RGD, is a next-generation adenovirus invented by company founder Dr. Juan Fueyo and Dr. Frank McCormick. - Website
http://www.dnatrix.com - Transaction Type
Debt - Transaction Amount
$1,543,905 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable. - M&A Terms
- Venture Investor
Undisclosed
